×
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80

12 Stocks Corporate Insiders are Abandoning

Posted on Thursday, June 30th, 2022 by MarketBeat Staff
An insider trade occurs when a corporate executive (such as a CEO, CFO, or COO) has non-public information about a company buys or sells shares of that company's stock. Company insiders are required by law to regularly report their stock purchases and sales to the SEC.

Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believe that the company is headed. If a number of insiders sell shares of their company, they may believe that the company will have weak future earnings and that the share price will decline in the near future.

For example, if Microsoft's CEO, CFO, and COO all recently sold shares of Microsoft stock, that would be an indication that there could be unreported news that may negatively affect Microsoft's stock price in the near future.

This slideshow lists the 12 companies that have had the highest levels of insider buying within the last 180 days.

#1 - Chevron (NYSE:CVX)

Dollar Amount of Shares Sold
$179,816,292.97
Number of Insider Stock Sales in the Last 180 Days
31
Volume of Shares Sold
1,200,841
Who Sold Shares
Colin E Parfitt (VP), David A Inchausti (insider), Eimear P Bonner (VP), Enrique Hernandez Jr (Director), James William Johnson (EVP), Joseph C Geagea (EVP), Mark A Nelson (EVP), Michael K Wirth (CEO), Pierre R Breber (CFO), R Hewitt Pate (VP), Rhonda J Morris (VP) and Wanda M Austin (Director)

Insider Trades by Quarter for Chevron (NYSE:CVX)

Chevron logoChevron Corporation, through its subsidiaries, engages in integrated energy and chemicals operations worldwide. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification associated with liquefied natural gas; transportation of crude oil through pipelines; and transportation, storage, and marketing of natural gas, as well as operates a gas-to-liquids plant.Read More 
 



#2 - Nexstar Media Group (NASDAQ:NXST)

Dollar Amount of Shares Sold
$54,231,491.78
Number of Insider Stock Sales in the Last 180 Days
19
Volume of Shares Sold
314,632
Who Sold Shares
Andrew Alford (Insider), Blake Russell (EVP), Brett Jenkins (EVP), Charles Thomas Mcmillen (Director), Dana Zimmer (Insider), Dennis Miller (Director), Elizabeth Ryder (EVP), Gary Weitman (Insider), John R Muse (Director), Karen A Brophy (Insider), Lisbeth Mcnabb (Director), Perry A Sook (CEO) and Thomas Carter (COO)

Insider Trades by Quarter for Nexstar Media Group (NASDAQ:NXST)

Nexstar Media Group logoNexstar Media Group, Inc, a television broadcasting and digital media company, focuses on the acquisition, development, and operation of television stations and interactive community websites and digital media services in the United States. The company offers free programming to television viewing audiences.Read More 
 



#3 - Pioneer Natural Resources (NYSE:PXD)

Dollar Amount of Shares Sold
$26,522,517.87
Number of Insider Stock Sales in the Last 180 Days
19
Volume of Shares Sold
108,337
Who Sold Shares
Chris J Cheatwood (EVP), Edison C Buchanan (Director), Frank A Risch (Director), J Kenneth Thompson (Director), Jerome D Hall Jr (EVP), Larry R Grillot (Director), Margaret Montemayor (CAO), Mark H Kleinman (EVP), Mark Stephen Berg (EVP), Matthew Gallagher (Director), Neal H Shah (CFO), Scott D Sheffield (CEO) and Tyson L Taylor (SVP)

Insider Trades by Quarter for Pioneer Natural Resources (NYSE:PXD)

Pioneer Natural Resources logoPioneer Natural Resources Company operates as an independent oil and gas exploration and production company in the United States. The company explores for, develops, and produces oil, natural gas liquids (NGLs), and gas. It has operations in the Midland Basin in West Texas. As of December 31, 2021, the company had proved undeveloped reserves and proved developed non-producing reserves of 130 million barrels of oil, 92 million barrels of NGLs, and 462 billion cubic feet of gas; and owned interests in 11 gas processing plants.Read More 
 



#4 - Pacira BioSciences (NASDAQ:PCRX)

Dollar Amount of Shares Sold
$10,091,132.18
Number of Insider Stock Sales in the Last 180 Days
21
Volume of Shares Sold
149,805
Who Sold Shares
Anthony Molloy (Insider), Charles A Reinhart III (CFO), Charles Anthony Laranjeira (Insider), Daryl Gaugler (COO), David M Stack (CEO), Gary W Pace (Director), John P Phd Longenecker (Director), Kristen Marie Williams (Insider), Lauren Bullaro Riker (SVP), Mark Froimson (Director), Max Reinhardt (Insider) and Roy Winston (Insider)

Insider Trades by Quarter for Pacira BioSciences (NASDAQ:PCRX)

Pacira BioSciences logoPacira BioSciences, Inc provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves.Read More 
 



#5 - Vertex Pharmaceuticals (NASDAQ:VRTX)

Dollar Amount of Shares Sold
$18,075,401.67
Number of Insider Stock Sales in the Last 180 Days
26
Volume of Shares Sold
66,501
Who Sold Shares
Bastiano Sanna (EVP), Charles F Wagner Jr (CFO), David Altshuler (EVP), Jeffrey M Leiden (Chairman), Joy Liu (SVP), Kristen Ambrose (CAO), Margaret G Mcglynn (Director), Ourania Tatsis (EVP), Reshma Kewalramani (CEO), Sangeeta N Bhatia (Director), Stuart A Arbuckle (COO) and Yuchun Lee (Director)

Insider Trades by Quarter for Vertex Pharmaceuticals (NASDAQ:VRTX)

Vertex Pharmaceuticals logoVertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation.Read More 
 



#6 - Datadog (NASDAQ:DDOG)

Dollar Amount of Shares Sold
$93,974,944.68
Number of Insider Stock Sales in the Last 180 Days
43
Volume of Shares Sold
661,200
Who Sold Shares
Adam Blitzer (COO), Amit Agarwal (Insider), David M Obstler (CFO), Dev Ittycheria (Director), Julie Richardson (Director), Kerry Acocella (General Counsel), Laszlo Kopits (General Counsel), Madre Armelle De (Insider), Matthew Jacobson (Director), Olivier Pomel (CEO), Sean Michael Walters (CRO) and Shardul Shah (Director)

Insider Trades by Quarter for Datadog (NASDAQ:DDOG)

Datadog logoDatadog, Inc provides monitoring and analytics platform for developers, information technology operations teams, and business users in the cloud in North America and internationally. The company's SaaS platform integrates and automates infrastructure monitoring, application performance monitoring, log management, and security monitoring to provide real-time observability of its customers technology stack.Read More 
 



#7 - Alexandria Real Estate Equities (NYSE:ARE)

Dollar Amount of Shares Sold
$8,065,678.95
Number of Insider Stock Sales in the Last 180 Days
12
Volume of Shares Sold
43,327
Who Sold Shares
Andres Gavinet (CAO), Hunter Kass (Director), Jackie B Clem (General Counsel), James P Cain (Director), Joseph Hakman (COO), Lawrence J Diamond (COO), Marc E Binda (EVP), Peter M Moglia (CEO), Stephen Richardson (CEO), Terezia C Nemeth (Director) and Vincent Ciruzzi (Insider)

Insider Trades by Quarter for Alexandria Real Estate Equities (NYSE:ARE)

Alexandria Real Estate Equities logoAlexandria Real Estate Equities, Inc (NYSE:ARE), an S&P 500<sup>®</sup> urban office real estate investment trust ("REIT"), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million square feet ("SF").Read More 
 



#8 - Zillow Group (NASDAQ:Z)

Dollar Amount of Shares Sold
$3,245,730.85
Number of Insider Stock Sales in the Last 180 Days
22
Volume of Shares Sold
63,753
Who Sold Shares
Aimee Johnson (CMO), Allen Parker (CFO), Arik Prawer (Insider), Dan Spaulding (Insider), David A Beitel (CTO), Erik C Blachford (Director), Errol G Samuelson (Insider), Gregory B Maffei (Director), Jennifer Rock (CAO), Jeremy Wacksman (COO) and Stanley B Humphries (CIO)

Insider Trades by Quarter for Zillow Group (NASDAQ:Z)

Zillow Group logoZillow Group, Inc, a digital real estate company, operates real estate brands on mobile applications and Websites in the United States. The company operates through three segments: Homes; Internet, Media & Technology; and Mortgages. The Homes segment is involved in resale of homes; and title and escrow services to home buyers and sellers, including title search procedures for title insurance policies, escrow, and other closing services.Read More 
 



#9 - Neurocrine Biosciences (NASDAQ:NBIX)

Dollar Amount of Shares Sold
$9,181,947.69
Number of Insider Stock Sales in the Last 180 Days
12
Volume of Shares Sold
108,395
Who Sold Shares
Darin Lippoldt (Insider), David W Boyer (Insider), Eiry Roberts (Insider), Gary A Lyons (Director), Julie Cooke (Insider), Kevin Charles Gorman (CEO), Kyle Gano (Insider), Matt Abernethy (CFO), Richard F Pops (Director), Stephen A Sherwin (Director) and William H Rastetter (Director)

Insider Trades by Quarter for Neurocrine Biosciences (NASDAQ:NBIX)

Neurocrine Biosciences logoNeurocrine Biosciences, Inc discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas.Read More 
 



#10 - Regeneron Pharmaceuticals (NASDAQ:REGN)

Dollar Amount of Shares Sold
$30,965,541.63
Number of Insider Stock Sales in the Last 180 Days
22
Volume of Shares Sold
45,659
Who Sold Shares
Arthur F Ryan (Director), Bonnie L Bassler (Director), George L Sing (Director), Joseph J Larosa (EVP), Leonard S Schleifer (CEO), Marc Tessier-Lavigne (Director), Marion Mccourt (EVP), Michael S Brown (Director), Plew Daniel P Van (EVP) and Robert E Landry (CFO)

Insider Trades by Quarter for Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Pharmaceuticals logoRegeneron Pharmaceuticals, Inc discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion.Read More 
 



#11 - ServiceNow (NYSE:NOW)

Dollar Amount of Shares Sold
$32,645,192.50
Number of Insider Stock Sales in the Last 180 Days
25
Volume of Shares Sold
58,856
Who Sold Shares
Chirantan Jitendra Desai (COO), Christopher Bedi (Insider), Frederic B Luddy (Director), Gina Mastantuono (CFO), Jacqueline P Canney (Insider), Lara Caimi (Insider), Paul John Smith (Insider), Russell S Elmer (General Counsel) and Teresa Briggs (Director)

Insider Trades by Quarter for ServiceNow (NYSE:NOW)

ServiceNow logoServiceNow, Inc provides enterprise cloud computing solutions that defines, structures, consolidates, manages, and automates services for enterprises worldwide. It operates the Now platform for workflow automation, artificial intelligence, machine learning, robotic process automation, performance analytics, electronic service catalogs and portals, configuration management systems, data benchmarking, encryption, and collaboration and development tools.Read More 
 



#12 - American Electric Power (NASDAQ:AEP)

Dollar Amount of Shares Sold
$5,366,646.60
Number of Insider Stock Sales in the Last 180 Days
15
Volume of Shares Sold
55,958
Who Sold Shares
Charles E Zebula (EVP), Charles R Patton (EVP), David Matthew Feinberg (EVP), Greg B Hall (EVP), Jospeh M Buonaiuto (Insider), Julia A Sloat (CFO), Lisa M Barton (COO), Nicholas K Akins (CEO), Paul Chodak III (EVP) and Therace Risch (EVP)

Insider Trades by Quarter for American Electric Power (NASDAQ:AEP)

American Electric Power logoAmerican Electric Power Company, Inc, an electric public utility holding company, engages in the generation, transmission, and distribution of electricity for sale to retail and wholesale customers in the United States. It operates through Vertically Integrated Utilities, Transmission and Distribution Utilities, AEP Transmission Holdco, and Generation & Marketing segments.Read More 
 



#13 - Altair Engineering (NASDAQ:ALTR)

Dollar Amount of Shares Sold
$1,296,875.59
Number of Insider Stock Sales in the Last 180 Days
22
Volume of Shares Sold
22,630
Who Sold Shares
Amy Messano (CMO), Brian Gayle (CAO), Gilma Saravia (Insider), James Ralph Scapa (CEO), Jeffrey Marraccini (Insider), Matthew Charles Brown (CFO), Nelson Dias (CRO), Raoul Maitra (Insider), Stephanie Buckner (COO) and Uwe Schramm (Insider)

Insider Trades by Quarter for Altair Engineering (NASDAQ:ALTR)

Altair Engineering logoAltair Engineering Inc, together with its subsidiaries, provides software and cloud solutions in the areas of simulation, high-performance computing, data analytics, and artificial intelligence worldwide. The company operates in two segments, Software and Client Engineering Services. The Software segment includes solvers and optimization technology products, high-performance computing software applications and hardware products, modeling and visualization tools, data analytics and analysis products, and Internet of Things platform and analytics tools, as well as support and the complementary software products.Read More 
 



 




MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.